Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Colorectal Neoplasms 13 Neoplasms 11 Pain, Postoperative 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neurotoxicity Syndromes 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Multiple Endocrine Neoplasia Type 1 3

Interventions

Propranolol 8 Timolol 5 Prednisolone 4 Prednisone 3 Adrenergic beta-Antagonists 3 Solutions 2 Saline Solution 2 Methylprednisolone 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Tomography, Optical Coherence 1 Steroids 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Nadolol 1 Mupirocin 1 Leuprolide 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 Gels 1 Everolimus 1 Bleomycin 1 Atenolol 1 Acebutolol 1 68Ga-1,4,7-triazacyclononane-N,N',N''-triacetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangioma × Sodium Chloride × Clear all

NCT01685398 2023-09-21

Topical Timolol for Superficial Infantile Hemangioma

Mahidol University

Phase 3 Completed

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡